MedMark Treatment Centers Opens Milford, Ohio Medication-Assisted Treatment Facility Serving Clermont and Hamilton Counties


“MedMark can help those struggling with opioid addiction in these areas of significant need throughout Ohio. Our goal is to bring hope back to these patients and their families.”

MedMark Treatment Centers, a BayMark Health Services company, announced the opening of a new medication-assisted treatment (MAT) facility in the Cincinnati, OH suburb of Milford. MedMark Milford provides proven treatment for adults struggling with opioid addiction including medication, counseling and support services. The clinic, located at 749C State Route 28 in Milford, is now accepting patients.

“In 2017, of the 4,300 opioid-related deaths in Ohio, 488 were reported in Hamilton and Clermont Counties,” said Frank Baumann, COO of BayMark Health Services. “Medication-assisted treatment with substance use counseling provides patients with the best chance for sustained recovery from their addiction and the opportunity to reclaim their lives. MedMark can help those struggling with opioid addiction in these areas of significant need throughout Ohio. Our goal is to bring hope back to these patients and their families.”

MedMark Treatment Centers are known across the country as leading providers of high-quality, proven treatment for opioid use disorder utilizing treatment medications including methadone and buprenorphine. MedMark programs support the use of MAT with addiction counseling and education, relapse prevention, lab testing, coordinated care for pregnancy and linkages to community resources to assist patients in achieving long-term recovery. MedMark Milford is the fourth program BayMark has opened in Ohio in 2019 under the MedMark Treatment Centers service brand. Our mission is to provide comprehensive medication-assisted treatment for opioid use disorder and other health care services to foster wellness, longevity and socially responsible behavior for the patients we serve.

David K. White, Ph.D., Chief Executive Officer, noted, “As the leader in providing specialized treatment for opioid use disorder, BayMark Health Services understands that patients benefit from access to a variety of proven treatment methods that meet them where they are at in their recovery journey. There is tremendous need across the country, but very few places have experienced devastation to the extent that they have in Ohio. BayMark has responded to that need by offering traditional structured medication-assisted treatment through our MedMark Treatment Services brand along with inpatient withdrawal management services by our New Vision brand and outpatient Suboxone® treatment through our AppleGate Recovery brand in Ohio.”

For more information on MedMark Milford and our services visit: http://MedMark.com or for admissions contact Meleah Naylor, Treatment Center Director, at 513.214.2094.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to 53,000+ patients in recovery from substance use disorder across the United States and Ontario, Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances. The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.

Share article on social media or email:

Leave a Reply